The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.

0315 GMT - Nine Entertainment could face near-term revenue challenges at its Stan streaming platform following the introduction of an ad-supported subscription tier, UBS analysts say. With an unchanged neutral rating on the stock, the analysts tell clients in a note that average revenue per user could soften as near-term ad revenues fail to fully offset lower-value subscriptions, which includes some existing customers trading down. UBS cuts its target price 24% to 79 Australian cents, which also reflects declines in shares of other streaming services. The stock is down 6.6% at 67.75 Australian cents. (stuart.condie@wsj.com)

0303 GMT - Thai lenders' 3Q loan growth is likely to be flat on quarter, says UOB Kay Hian's Thanawat Thangchadakorn in a note. He says banks could be cautious around lending and focus mainly on corporate loans. However, credit costs for the banks covered by the brokerage are likely to decline on year and on quarter, he says. Many banks booked special provisions in 1Q to cushion against adverse effects from the Middle East conflict, but these pressures didn't show up in the lenders' 1H earnings, he adds. Expectations for a Federal Reserve rate increase could also be a tailwind for major Thai lenders, he says. UOB Kay Hian maintains an overweight call for the Thai banking sector.(megan.cheah@wsj.com)

0302 GMT - UMS Integration is positioned to benefit from the AI-led semiconductor cycle that will drive the precision-engineering company's earnings, says Citi analyst Arthur Pindea in a note. Revenue is expected to grow at an annualized 32% and earnings per share at 38% over FY25-28, the bank estimates. Organic growth from long-standing client Applied Materials and market-share gains through new client Lam Research will also support earnings. Scale efficiencies and a sustained net cash position could open room for progressively higher dividends, Citi adds. The bank initiates coverage at buy/high risk with a target price of 3.43 Singapore dollars. Shares are up 4.9% at S$2.78. (venkat.pr@wsj.com)

0301 GMT - IAG's bulls at UBS are untroubled by the latest blow to its bid for control of Western Australia state insurer RACI. Australia's competition regulator blocked IAG's second application for clearance of the acquisition. IAG will ask for permission one more time, but UBS analysts see upside risk to consensus EPS forecasts irrespective of the outcome. They tell clients in a note that they anticipate EPS accretion of between 5% and 10% if IAG gets hold of RACI. They think IAG would respond to failure with a A$750 million buyback that would be 1%-5% EPS accretive. UBS keeps a buy rating on the stock with a target price of 9.25 Australian dollars. Shares are down 0.9% at A$7.81. (stuart.condie@wsj.com)

0241 GMT - Yutong could continue to face valuation pressures from uncertainty on stricter European Union rules and its overseas export strategy, Citi analyst Jeff Chung says in a note, pointing to the share price's underperformance. Up to 80% of recurring net profit could be affected in the worst-case scenario, though that impact might only be felt in 2028, the analyst says. The bank says the uncertainty might continue to hurt Yutong's valuation more than its long-term earnings. Citi keeps its buy rating on the stock with a target price of 41.70 yuan. Shares are up 2.7% at 25.94 yuan. (venkat.pr@wsj.com)

0238 GMT - City Developments' strategic review could point to a more disciplined approach toward capital management and long-term value creation, which could enhance its return on equity, UOB Kay Hian's Lock Mun Yee says in a note. She expects the review to provide more clarity on the Singapore property company's opportunities for asset sales and redevelopment. Potential divestments could include assets in the U.K. and China, the analyst adds. These could boost its share price and narrow its gap to its net asset value, she says. The strategic review outcome is due Monday. UOB Kay Hian raises its target price to 11.85 Singapore dollars from S$11.50 to reflect a higher revalued net asset value. It retains its buy rating. Shares decline 1.7% to S$8.28. (megan.cheah@wsj.com)

0229 GMT - How the National Stock Exchange of India's trading debut goes will depend heavily on market sentiment, says Apurva Sheth at Samco Securities. The debut comes against a backdrop of rising bond yields headlined by the U.S. 10-year crossing 5%, which is generally negative for equities. But Sheth notes that the NSE IPO was priced significantly below the levels at which it was trading in the unlisted market, so he expects the stock to list at a premium. Post-listing, he sees the chances of a major fall below the issue price as relatively limited. Even if a large portion of retail investors sell in the first hour or two, that should be absorbable by the market, Sheth adds, noting that roughly 35% of the issue size was reserved for retail investors. (fabiana.negrinochoa@wsj.com)

0220 GMT - Malaysian healthcare sector could remain supported by the rising prevalence of non-communicable diseases, an ageing population, and increasing health awareness, CIMB Securities analyst Chun Sung Oong says in a note. He pegs IHH Healthcare as his new top pick, citing its stronger earnings visibility. IHH's business is expected to benefit from patients shifting to private hospitals amid high occupancy at public hospitals. In India, Gleneagles India's profitability is expected to improve as it works more closely with Fortis Healthcare. The potential IPO of AsiaOne Healthcare could renew investor interest in Malaysia's healthcare sector, as the listing could support higher valuations, he adds. CIMB maintains an overweight rating on the Malaysian healthcare sector. (yingxian.wong@wsj.com)

0200 GMT - Keppel REIT's divestment of T Tower could pave the way for further asset sales and unit buybacks, potentially providing catalysts for the units, Citi analyst Brandon Lee says in a note. While noting the T Tower sale could result in a roughly 1% distribution per unit dilution, Citi has a positive view of the divestment. The bank, which keeps its neutral rating with a target price of 0.95 Singapore dollar, adds a 30-day upside catalyst for Keppel REIT. Units are down 1.2% at S$0.85. (venkat.pr@wsj.com)

0130 GMT - Boycott-related pressures on Nestle (Malaysia) stemming from the Israel-Hamas war have likely eased, with their impact on earnings expected to fade further, says AmInvestment Bank analyst Heng Yii Paul in a note. The stock is down more than 25% from its January high, but boycott concerns and rising input costs have mostly run their course, he says. Margins could temporarily weaken as El Nino pushes up commodity prices though past episodes suggest the impact typically lasts one to two quarters. Restructuring efforts could also improve profitability, with more cost cuts likely in Malaysia. He views the current stock price as an attractive entry point, with the risk-reward ratio skewed to the upside. AmInvestment Bank is reinitiating coverage with a buy rating and a 135-ringgit target price. Shares are 0.5% lower at 89.04 ringgit.(yingxian.wong@wsj.com)

0047 GMT - Site visits to Evolution Mining's Cowal and Northparkes operations showed that "clear growth opportunities lie ahead," says UBS. It upgrades the stock to buy from neutral, and raises its target to 16.00 Australian dollars a share from A$15.20. "As EVN advances these initiatives, we update our modelling to reflect a pathway to over 900,000 oz per annum of gold and circa 120,000 tons per annum of copper production by FY32, driven by upside potential at Cowal, with no material changes to near-term numbers," UBS says. Cowal, which generates roughly 40% of the company's free cash flow today, continues to offer the most compelling growth options in Evolution's portfolio, says the bank. Shares are down 1.7% at A$13.71. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)

0034 GMT - Premier Investments' annual result shows solid cost control by the Australian retailer, RBC Capital Markets analyst Michael Toner says. Premier's fiscal 2026 cost-of-doing-business growth was 60 basis points above Toner's forecast, but he looks deeper to see employee expenses, advertising and marketing, and rent declining by between 1% and 4% compared with a year earlier. Toner, who has a neutral rating on the stock, tells clients in a note that operating cash flow across the group was also strong, beating his estimate by 12%. RBC has a last-published target price of 12.00 Australian dollars on the stock, which is up 4.5% at A$11.665.